These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 7573496

  • 41. Attenuation of experimental subarachnoid hemorrhage--induced cerebral vasospasm by the adenosine A2A receptor agonist CGS 21680.
    Lin CL, Shih HC, Lieu AS, Lee KS, Dumont AS, Kassell NF, Howng SL, Kwan AL.
    J Neurosurg; 2007 Mar; 106(3):436-41. PubMed ID: 17367066
    [Abstract] [Full Text] [Related]

  • 42. [Pathogenesis of cerebral vasospasm following subarachnoid hemorrhage].
    Sasaki T.
    No To Shinkei; 1993 Sep; 45(9):799-808. PubMed ID: 8217406
    [No Abstract] [Full Text] [Related]

  • 43. Effect of remacemide hydrochloride on subarachnoid hemorrhage-induced vasospasm in rabbits.
    Zuccarello M, Lewis AI, Upputuri S, Farmer JB, Anderson DK.
    J Neurotrauma; 1994 Dec; 11(6):691-8. PubMed ID: 7723068
    [Abstract] [Full Text] [Related]

  • 44. Clazosentan, an endothelin receptor antagonist, prevents early hypoperfusion during the acute phase of massive experimental subarachnoid hemorrhage: a laser Doppler flowmetry study in rats.
    Schubert GA, Schilling L, Thomé C.
    J Neurosurg; 2008 Dec; 109(6):1134-40. PubMed ID: 19035733
    [Abstract] [Full Text] [Related]

  • 45. Two indices of functional damage of the artery wall parallel the time course of irreversible narrowing in experimental vasospasm in the rabbit.
    Vorkapic P, Bevan JA, Bevan RD.
    Blood Vessels; 1991 Dec; 28(1-3):179-82. PubMed ID: 2001468
    [Abstract] [Full Text] [Related]

  • 46. Prevention of cerebral vasospasm by actinomycin D.
    Shigeno T, Mima T, Yanagisawa M, Saito A, Goto K, Yamashita K, Takenouchi T, Matsuura N, Yamasaki Y, Yamada K.
    J Neurosurg; 1991 Jun; 74(6):940-3. PubMed ID: 2033454
    [Abstract] [Full Text] [Related]

  • 47. Vasospasm following subarachnoid hemorrhage: evidence against functional upregulation of protein kinase C constrictor pathway.
    Yoon S, Zuccarello M, Rapoport RM.
    Neurol Res; 2003 Apr; 25(3):268-70. PubMed ID: 12739235
    [Abstract] [Full Text] [Related]

  • 48. Release of endothelium-derived relaxing factor after subarachnoid hemorrhage.
    Kim P, Lorenz RR, Sundt TM, Vanhoutte PM.
    J Neurosurg; 1989 Jan; 70(1):108-14. PubMed ID: 2783340
    [Abstract] [Full Text] [Related]

  • 49. Effects of CD-349, a dihydropyridine derivative, on contraction induced by vasoactive agents in canine basilar artery after subarachnoid hemorrhage.
    Kamata K, Nishiyama H, Miyata N, Kasuya Y.
    Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):143-60. PubMed ID: 1876747
    [Abstract] [Full Text] [Related]

  • 50. Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys.
    Hino A, Weir BK, Macdonald RL, Thisted RA, Kim CJ, Johns LM.
    J Neurosurg; 1995 Sep; 83(3):503-9. PubMed ID: 7666230
    [Abstract] [Full Text] [Related]

  • 51. Gene transfer to cerebral blood vessels after subarachnoid hemorrhage.
    Muhonen MG, Ooboshi H, Welsh MJ, Davidson BL, Heistad DD.
    Stroke; 1997 Apr; 28(4):822-8; discussion 828-9. PubMed ID: 9099203
    [Abstract] [Full Text] [Related]

  • 52. Possible role of endothelin in the pathogenesis of cerebral vasospasm.
    Shigeno T, Mima T, Yanagisawa M, Saito A, Fujimori A, Shiba R, Goto K, Kimura S, Yamashita K, Yamasaki Y.
    J Cardiovasc Pharmacol; 1991 Apr; 17 Suppl 7():S480-3. PubMed ID: 1725419
    [Abstract] [Full Text] [Related]

  • 53. Characterization of the endothelin-B receptor expression and vasomotor function during experimental cerebral vasospasm.
    Vatter H, Konczalla J, Weidauer S, Preibisch C, Raabe A, Zimmermann M, Seifert V.
    Neurosurgery; 2007 Jun; 60(6):1100-8; discussion 1108-9. PubMed ID: 17538385
    [Abstract] [Full Text] [Related]

  • 54. The effect of subarachnoid hemorrhage on mechanisms of vasodilation mediated by cyclic adenosine monophosphate.
    Onoue H, Katusic ZS.
    J Neurosurg; 1998 Jul; 89(1):111-7. PubMed ID: 9647181
    [Abstract] [Full Text] [Related]

  • 55. Impairment of endothelium-dependent relaxation in human basilar artery after subarachnoid hemorrhage.
    Hatake K, Wakabayashi I, Kakishita E, Hishida S.
    Stroke; 1992 Aug; 23(8):1111-6; discussion 1116-7. PubMed ID: 1636187
    [Abstract] [Full Text] [Related]

  • 56. Vasospasm following subarachnoid hemorrhage: evidence against functional upregulation of Rho kinase constrictor pathway.
    Yoon S, Sherman JD, Zuccarello M, Rapoport RM.
    Neurol Res; 2002 Jun; 24(4):392-4. PubMed ID: 12069288
    [Abstract] [Full Text] [Related]

  • 57. Systemic administration of an inhibitor of endothelin-converting enzyme for attenuation of cerebral vasospasm following experimental subarachnoid hemorrhage.
    Caner HH, Kwan AL, Arthur A, Jeng AY, Lappe RW, Kassell NF, Lee KS.
    J Neurosurg; 1996 Nov; 85(5):917-22. PubMed ID: 8893732
    [Abstract] [Full Text] [Related]

  • 58. Cerebral aterial spasm. I. Adrenergic mechanism in experimental cerebral vasospasm.
    Morooka H.
    Acta Med Okayama; 1978 Apr; 32(1):23-37. PubMed ID: 148833
    [Abstract] [Full Text] [Related]

  • 59. Prevention of delayed vasospasm by an endothelin ETA receptor antagonist, BQ-123: change of ETA receptor mRNA expression in a canine subarachnoid hemorrhage model.
    Itoh S, Sasaki T, Asai A, Kuchino Y.
    J Neurosurg; 1994 Nov; 81(5):759-64. PubMed ID: 7931624
    [Abstract] [Full Text] [Related]

  • 60. Antisense preproendothelin-oligoDNA therapy for vasospasm in a canine model of subarachnoid hemorrhage.
    Ohkuma H, Parney I, Megyesi J, Ghahary A, Findlay JM.
    J Neurosurg; 1999 Jun; 90(6):1105-14. PubMed ID: 10350259
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.